X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (386) 386
Publication (44) 44
Book Chapter (34) 34
Book Review (34) 34
Conference Proceeding (13) 13
Magazine Article (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (247) 247
humans (238) 238
pathology (157) 157
female (142) 142
male (136) 136
middle aged (130) 130
aged (118) 118
pancreatic neoplasms - pathology (112) 112
adult (100) 100
surgery (92) 92
pancreas (84) 84
cancer (78) 78
carcinoma (65) 65
oncology (61) 61
aged, 80 and over (60) 60
immunohistochemistry (60) 60
prognosis (54) 54
adenocarcinoma (50) 50
carcinoma, pancreatic ductal - pathology (47) 47
adenocarcinoma - pathology (46) 46
pancreatic cancer (43) 43
abridged index medicus (41) 41
tumors (41) 41
pancreatic neoplasms - metabolism (40) 40
article (39) 39
gastroenterology & hepatology (37) 37
expression (35) 35
medicine & public health (35) 35
pancreatic neoplasms - genetics (33) 33
diagnosis, differential (31) 31
neoplasm staging (31) 31
intraepithelial neoplasia (28) 28
neoplasm invasiveness (27) 27
analysis (26) 26
biomarkers, tumor - analysis (26) 26
carcinoma in situ - pathology (26) 26
diagnosis (26) 26
ductal adenocarcinoma (26) 26
pancreatic neoplasms - diagnosis (26) 26
retrospective studies (25) 25
gastroenterology and hepatology (24) 24
pancreatic neoplasms - surgery (24) 24
animals (23) 23
classification (22) 22
mutation (22) 22
pancreatic neoplasms - mortality (22) 22
survival rate (22) 22
adenocarcinoma - metabolism (21) 21
adenocarcinoma, mucinous - pathology (21) 21
mice (21) 21
survival (21) 21
treatment outcome (21) 21
medical laboratory technology (20) 20
adenocarcinoma - mortality (19) 19
predictive value of tests (19) 19
biomarkers, tumor - metabolism (17) 17
carcinoma, pancreatic ductal - metabolism (17) 17
follow-up studies (17) 17
research (17) 17
survival analysis (17) 17
metastasis (16) 16
pancreatic neoplasms - classification (16) 16
young adult (16) 16
adenocarcinoma - diagnosis (15) 15
carcinoma, pancreatic ductal - genetics (15) 15
carcinoma, papillary - pathology (15) 15
chemotherapy (15) 15
features (15) 15
gallbladder (15) 15
kaplan-meier estimate (15) 15
pancreaticoduodenectomy (15) 15
carcinoma, pancreatic ductal - diagnosis (14) 14
gastroenterology (14) 14
k-ras (14) 14
pancreas - pathology (14) 14
pancreatic ducts - pathology (14) 14
pancreatic neoplasms - drug therapy (14) 14
proportional hazards models (14) 14
tumor (14) 14
adenocarcinoma - surgery (13) 13
dysplasia (13) 13
gemcitabine (13) 13
gene expression regulation, neoplastic (13) 13
liver (13) 13
bile duct neoplasms - pathology (12) 12
cell differentiation (12) 12
disease-free survival (12) 12
health aspects (12) 12
lesions (12) 12
management (12) 12
mucins - metabolism (12) 12
neoplasms (12) 12
ampulla of vater - pathology (11) 11
breast (11) 11
clinicopathological features (11) 11
cystadenocarcinoma (11) 11
gallbladder neoplasms - pathology (11) 11
multivariate analysis (11) 11
neoplasm (11) 11
pancreatic adenocarcinoma (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Pathology, ISSN 0031-3025, 02/2018, Volume 50, pp. S10 - S10
Journal Article
Pathology, ISSN 0031-3025, 02/2018, Volume 50, pp. S10 - S10
Journal Article
Pathology, ISSN 0031-3025, 02/2018, Volume 50, pp. S12 - S12
Journal Article
Pathology, ISSN 0031-3025, 02/2018, Volume 50, pp. S12 - S12
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 02/2012, Volume 122, Issue 2, pp. 639 - 653
Journal Article
American Journal of Surgical Pathology, ISSN 0147-5185, 12/2015, Volume 39, Issue 12, pp. 1730 - 1741
Journal Article
Cancer Letters, ISSN 0304-3835, 2013, Volume 341, Issue 2, pp. 195 - 203
Highlights • EF31 and UBS109 are more potent inhibitors of DNA methylation than curcumin. • EF31 and UBS109 inhibit DNA methylation through NF-κB and HSP90... 
Hematology, Oncology and Palliative Medicine | UBS109 | DNA methylation | Curcumin | Pancreatic cancer | EF31 | CELLS | APOPTOSIS | SPARC | ANGIOGENESIS | DUCTAL ADENOCARCINOMA | TRANSCRIPTION | INTRAEPITHELIAL NEOPLASIA | ABERRANT METHYLATION | INHIBITION | ONCOLOGY | CPG ISLANDS | Immunohistochemistry | Curcumin - analogs & derivatives | Pancreatic Neoplasms - metabolism | Cadherins - metabolism | Humans | DNA (Cytosine-5-)-Methyltransferases - metabolism | Dose-Response Relationship, Drug | Pancreatic Neoplasms - drug therapy | Osteonectin - genetics | Cytosine - metabolism | Female | HSP90 Heat-Shock Proteins - genetics | Gene Expression Regulation, Neoplastic - drug effects | Cadherins - genetics | Cell Survival - drug effects | Pyridines | DNA (Cytosine-5-)-Methyltransferase 1 | Curcumin - pharmacology | Osteonectin - metabolism | Pancreatic Neoplasms - genetics | Piperidones - pharmacology | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Xenograft Model Antitumor Assays | DNA (Cytosine-5-)-Methyltransferases - genetics | Animals | Mice, Nude | Cell Line, Tumor | HSP90 Heat-Shock Proteins - metabolism | Cell Proliferation - drug effects | Mice | DNA Methylation - drug effects | Development and progression | Genetic aspects | Methylation | DNA | Cancer | Proteins | Cyclin-dependent kinases | Cell cycle | Epigenetics | Pancreas | Kinases | Gene expression | Cancer therapies | Deoxyribonucleic acid--DNA | Apoptosis | Index Medicus
Journal Article
13.